Hi freebooter,
I quote your words here and agree entirely. It is also something most here at HC don't want to hear ... but it's the truth.
Most of the complaints are aimed at blaming someone else for an investment that the shareholder is actually in control off.
No one else authorises the buy, sell or hold of the investment. Company presentations all have a disclaimer about
investment advice for a reason.
I understand why people might be upset, but unfortunately, many complaining seem to also have expectations not aligned
with the risk undertaken. This is a high-risk game. Its just as easy to win big or go home with nothing in your pockets.
Yes, the bottom line is bio-tech is risky ... you can win big and you can also 'do the lot'.
As part of the 'defense of PH team', a group shrinking by the day it seems ... I would suggest one thing about this sell off -
If Paul or his family need money to cover a tax debt, and if it was difficult to find from another source (I don't know PH's
personal situation), then a sale of IMU shares is probably the one that will impact shareholders least. I say this considering
IMU's MC of 622.2 million, compared to say CHM's MC of 24.7 million or RAD's $20.8 million. If the sale had occurred in
either of CHM or RAD the impact might have been catastrophic for those companies. Yes, we here at IMU have had another
'oh no' moment, but this may have been at the forefront of PH's thoughts. We will never know, its just something you will
see if you take a wider view. The current SP is depressing, and personally I'm wondering if I will see any value from
my IMUODs, I don't know.
What I do see is some very, very promising trials coming together, which if successful, will save many lives ...
and perhaps makes share holders some money. Holders need to decide if its worth the wait. Your choice.
Just a few thoughts from one holder.
Expand
(20min delay)